In conclusion, our study reports a potential lead from Withaferin A isoxazoline derivatives (W-2b) that induces premature senescence as an antitumor safeguard mechanism against proliferating cancer cells through activation of tumor suppressor Chk2. The gene discussed is CHEK2; the disease is cancer.